Erik WambreAssociate Director, Translational and Clinical Immunology at Benaroya Research Institute at Virginia Mason

Dr. Wambre was born and raised in France. He received his MS degree in Molecular Biology from the University of Lille in 2003 and his Master of Business Engineering (MBE) from the Ecole de Biologie Industrielle (Cergy) in 2004. In 2005, he joined Stallergenes, world leader in sublingual immunotherapy, as a project leader. In parallel, he attended the University Pierre & Marie Curie (Paris 6) in 2008, receiving his PhD in Immunology and “Louis Forest” award for best Life Science thesis (Sorbonne, 2009).

After his background in Europe, Dr. Wambre joined the Benaroya Research Institute in 2009 to complete a postdoctoral fellowship and subsequently became an Assistant Member. Area of Research The projects in Dr. Wambre’s laboratory are focused on providing in depth immune monitoring of antigen-specific T cell responses in allergy and cancer vaccine development. The primary objectives are to enhance our understanding of the pathogenesis, regulation and functions of the adaptive immune system in disease pathways. Further questions relate to the correlation between clinical responses and immunological changes in the course of immunotherapy. Translational and clinical applications include identification of biomarkers of clinical interest, and development of new vaccination strategies.